Pulmonary hypertension treatments continue to evolve and one very promising advancing treatment option is inhaled therapy which delivers medication directly to the lungs.
The webinar speakers will discuss the current landscape and future of inhaled therapies in pulmonary hypertension, including:
• Currently approved inhaled therapies.
• Key differences between inhaled treatment options and the conditions they manage, including pulmonary hypertension with interstitial lung disease (PH-ILD).
• New and emerging therapies being studied in clinical trials.
• Practical information about safely managing and using inhaled therapies.
The webinar will be available in English and Spanish.
Register here